Overall, our findings suggest that the inhibition of the PD-1/PD-L1 axis may be effective in induction chemotherapy without the development of drug resistance in cancer, as it provides effective immune checkpoint blockade and thus may be a new approach to increase the first-line efficacy of chemotherapy. Here, CD274 is linked to cancer.